Global Gastrointestinal Bleeding Treatment Market to Gain $825 Million by 2028

Global Gastrointestinal Bleeding Treatment Market

This report describes and evaluates the worldwide gastrointestinal bleeding treatment devices market. It covers three five-year time frames, including 2015 to – 2020, named the notable time frame, 2018-2025 figure period and 2025-2030 a further gauge period.

Gastrointestinal Bleeding Treatment Market By Product (Endoscopic Hemostatic Devices, Thermal Devices, Mechanical Device, Closure Devices, and Others), By GI Tract Division (Upper and Lower), and By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025. covers major gastrointestinal bleeding treatment devices companies, gastrointestinal bleeding treatment devices market share by company, gastrointestinal bleeding treatment devices manufacturers, gastrointestinal bleeding treatment devices market size, and gastrointestinal bleeding treatment devices market forecasts. The report also covers the global gastrointestinal bleeding treatment devices market and its segments.

Global Gastrointestinal Bleeding Treatment Market
Global Gastrointestinal Bleeding Treatment Market

Worldwide Gastrointestinal Bleeding Treatment Market Trends

Endoscopic hemostasis has gained significant traction as an approach to treat GI bleeding. Established treatment modes include mechanical therapy, injection therapy and thermal therapy. The approach is well known for its ability to reduce mortality associated with GI bleeding.

Driving innovative improvements being developed of hemostatic splashes and stents are being taken on to stop GI dying. This is relied upon to expand the gastrointestinal draining treatment market later on.

Worldwide Gastrointestinal Bleeding Treatment Market: Product Insights

Endoscopic hemostatic gadgets are expected to represent the greater part of the absolute gastrointestinal draining treatment market all through the conjecture time frame. Among these gadgets, the mechanical gadgets sub-portion is set to enroll greatest development.

Expanded use of these device for first line of treatment is a vital driver behind the sub-section’s development. The Mechanical Devices sub-section is set to grow at a noteworthy CAGR of 4.5% during the gauge time frame.

COVID-19 Market Insights:

The COVID-19 pandemic has huge repercussions for gastrointestinal draining treatment market. Up to this point, it was theorized that the COVID-19 infection basically taints respiratory epithelial cells, and is communicated through respiratory drops.

In any case, a few reports produced from a review led in February 2020 identified SARS-CoV-2 viral RNA in feces tests. Waste mysterious blood testing demonstrated an upper gastrointestinal drain in one of the patients.

Before the respiratory indications showed, numerous patients revealed extreme instances of the runs, sickness, regurgitating and stomach inconvenience. Consequently, it is basic to shield GI problems patients from the COVID-19 assault.

Significant GI draining business sector players have accordingly smoothed out their creation to meet the thriving requirements of medical services suppliers. Erbe Elektromedizin GmBh, is guaranteeing security of supply so as not to encounter any deficiency of fundamental clinical hardware. They have acquainted shift-based tasks with guarantee practical creation.

On a comparable plane, Cook Medical has executed shift changes and is intently checking its natural substance production network. The organization delivers the Instinct TM Endoscopic Hemoclip, with the end goal of endoscopic stamping and hemostasis for draining ulcers.

Besides, medical clinics, facilities, and other medical care settings are occupied with basic administration of endoscopes, endoscope reprocessing, and capacity regions for gastrointestinal therapy purposes.

These incorporate undeniable level sanitization through manual cleaning, reprocessing of endoscopes by experienced staff, and fastidious room cleaning post each strategy.

Key Findings of Global Gastrointestinal Bleeding Treatment Market Study:

  • Under the GI tract division, segment of upper GI is anticipated to continue dominating the global gastrointestinal bleeding treatment market landscape over the forecast period
  • It will record a notable compound annual growth rate owing to high and growing incidence and prevalence of upper GI tract bleeding
  • Rapidly ageing population is another notable growth propeller in the segment and it is believed that two billion people will occupy the age group of 60 and above by 2050
  • As far as the end-user category is concerned, prominent share of the market was held by hospitals in 2017 and the trend is expected to sustain itself over the forecast period


The “Worldwide Gastrointestinal Bleeding Treatment Market Analysis to 2028” is a specific and top to bottom investigation of the drug business with an exceptional spotlight on the worldwide market pattern examination. The report plans to give an outline of Gastrointestinal Bleeding Treatment market with nitty gritty market division by Product, GI Tract, End User and topography. The worldwide Gastrointestinal Bleeding Treatment market is relied upon to observe high development during the conjecture time frame. The report gives key insights available status of the main Gastrointestinal Bleeding Treatment market players and offers key patterns and valuable open doors on the lookout.

Gastrointestinal Bleeding Treatment Market segmentation on the basis of product, GI tract division, end-users and key regions.


  • Endoscopic Hemostatic Devices
  • Thermal Devices
  • Mechanical Devices
  • Closure Devices
  • Others

GI Tract Division

  • Upper GI Tract
  • Lower GI Tract


  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Key Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


  • Erbe Elektromedizin
  • CONMED Corporation
  • Ovesco Endoscopy
  • U.S. Medical Innovations
  • Boston Scientific Corporation.
Hi, I’m Myrna Bailey